Dextran Sodium Sulphate-Induced Gastrointestinal Injury Further Aggravates the Impact of Galantamine on the Gastric Myoelectric Activity in Experimental Pigs

Galantamine has been used as a treatment for Alzheimer disease. It has a unique, dual mode of action (inhibitor of acetylcholinesterase and allosteric modulator of nicotinic acetylcholine receptors). Nausea (in about 20%), vomiting (10%) and diarrhoea (5–7%) are the most common side effects. The aim...

Descripció completa

Dades bibliogràfiques

Autors principals:	Jan Bures, Ilja Tacheci, Jaroslav Kvetina, Vera Radochova, Darina Kohoutova, Martin Valis, Stanislav Rejchrt, Veronika Knoblochova, Jana Zdarova Karasova
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2021-06-01
Col·lecció:	Pharmaceuticals
Matèries:	Alzheimer disease galantamine electrogastrography experimental pigs gastric motor dysmotility small bowel transit time
Accés en línia:	https://www.mdpi.com/1424-8247/14/6/590
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!